N@N

Ryan & Maniskas, LLP Announces Investigation of Continucare Corp.

_{//health-fitness.news-articles.net/content/2011/ .. announces-investigation-of-continucare-corp.html}
^{Published in Health and Fitness on Tuesday, June 28th 2011 at 7:30 GMT by Market Wire}  

WAYNE, Pa.--([ BUSINESS WIRE ])--Ryan & Maniskas, LLP ([ www.rmclasslaw.com/cases/cnu ]) is investigating potential claims against the board of directors of Continucare Corp. ("Continucare" or the "Company") (NYSE: CNU) concerning possible breaches of fiduciary duty and other violations of law related to the Companya�s efforts to sell Continucare to Metropolitan Health Networks, Inc. (aMetropolitana) in a transaction valued at approximately $416 million.

Our investigation concerns possible breaches of fiduciary duty and other violations of law related to the approval of the transaction by Companya�s board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of Continucare. For more information regarding our investigation, please contact Ryan & Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at (877) 316-3218 or by email at [ rmaniskas@rmclasslaw.com ] or visit: [ www.rmclasslaw.com/cases/cnu ].

Under the terms of the definitive agreement, Continucare shareholders will get $6.25 in cash and 0.0414 of Metropolitan common stock for each share that they own.

If you own shares of Continucare and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: [ www.rmclasslaw.com/cases/cnu ]. You may also email Mr. Maniskas at [ rmaniskas@rmclasslaw.com ]. For more information about class action cases in general, please visit our website: [ www.rmclasslaw.com ].

Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.